Al hussein universty hospital
Cairo, Nasr City, Egypt
NCT Number: NCT07786376
The goal of this study is to evaluate the diagnostic performance of an Artificial Intelligence (AI) algorithm in the histopathological diagnosis of bcc compared to certified dermatopathologists
Trial opening soon.
Get NotifiedAll sexes
Observational
Cairo, Nasr City, Egypt
Background Basal cell carcinoma (BCC) is the most commonly diagnosed skin cancer worldwide and the predominant form of non-melanoma skin cancers (NMSCs), with an escalating global incidence. Histopathology remains the gold standard for diagnosis; however, manual analysis is labor-intensive, time-consuming, and subject to increasing pressure amid a global shortage of board-certified dermatopathologists. Digital pathology and whole-slide imaging (WSI), combined with advanced artificial intelligence (AI) models such as vision transformers and large language models (e.g., HistoGPT), offer a transformative solution to automate and streamline dermatopathological diagnostics.
Aim of the Work This study aims to evaluate the diagnostic performance and processing efficiency of the AI algorithm HistoGPT in the histopathological diagnosis of basal cell carcinoma compared to certified dermatopathologists.
Methodology This retrospective, blinded, comparative study will be conducted using archived H&E-stained glass slides retrieved from the pathology archive of the Al-Hussein Dermatopathology Unit between 2010 and 2019. Slides meeting the inclusion criteria will be digitized into high-resolution Whole Slide Images (WSIs) at 40× magnification using the Leica Aperio GT450 scanner. The digitized WSIs will be processed and analyzed through the HistoGPT cloud platform to automatically generate diagnostic reports and classifications. The AI-generated findings will be systematically compared against the reference standard diagnoses established by a panel of certified dermatopathologists under the supervision of Prof. Hussein Hasb El-Nabi. Diagnostic accuracy, concordance, and turnaround time will be evaluated.
Statistical Analysis Data will be analyzed using SPSS (version 26.0) or R-programming. Categorical variables will be compared using appropriate statistical tests, and a $p$-value of $< 0.05$ will be considered statistically significant.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: one year
Contact information is provided by the study sponsor or research team.
Al-Azhar University
Other
Evaluation of Artificial Intelligence Algorithms Performance in the Histopathological Diagnosis of Basal Cell Carcinoma
Acronym: AI\bcc
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06398418
Adenoma, Basal Cell Cancer
Nashville, Tennessee, United States
View Trial DetailsNCT04552990
BCC, BCC - Basal Cell Carcinoma
New York, United States
View Trial DetailsNCT03509467
Basal Cell Cancer, Basal Cell Carcinoma
Tampa, Florida, United States
View Trial DetailsNCT07068568
Basal Cell Cancer, Basal Cell Carcinoma (BCC)
Naples, Campania, Italy
View Trial Details